Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1

Journal of Medical Virology

Volumn 70, Issue 2, 2003, Pages 253-257

  McClain, Micah T ^a,b   Rapp, Erin C ^a   Harley, John B ^a,b,c   James, Judith A ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c US Department of Veteran Affairs   (United States)

Author keywords

Autoimmunity; EBNA 1; EBV; SLE; SM B'

Indexed keywords

ALANINE; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1; GLYCINE; IMMUNOGLOBULIN G ANTIBODY; OCTAPEPTIDE; PROLYLPROLYLPROLYLGLYCYLMETHIONYLARGINYLPROLYLPROLINE; PROLYLPROPLYLPROLYLGLYCYLARGINYLARGINYLPROLYLPHENYLALANYLPHENYLALANYLHISTID YLPROLYLVALYLGLYCYLGLUTAMYLALANINE; PROTEIN SM B'; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; EPITOPE MAPPING; EPSTEIN BARR VIRUS; HUMAN; IMMUNOREACTIVITY; INFECTIOUS MONONUCLEOSIS; NONHUMAN; SEROCONVERSION; SPLICEOSOME;

AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; AUTOANTIGENS; CROSS REACTIONS; EPITOPE MAPPING; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; INFECTIOUS MONONUCLEOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; PEPTIDES; RIBONUCLEOPROTEINS, SMALL NUCLEAR;

HUMAN HERPESVIRUS 4;

EID: 0037410452     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10385     Document Type: Article

References (12)

1. Arbuckle MR, Schilling AR, Harley JB, James JA. 1998. A limited lupus anti-spliceosomal response targets a cross-reactive proline-rich motif. J Autoimmun 11:1-8.
2. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ. 2001. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286:3083-3088.
3. Cheng HM, Foong YT, Sam CK, Prasad U, Dillner J. 1991. Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors. J Clin Microbiol 29:2180-2186.
4. Henle G, Henle W, Horwitz CA. 1974. Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. J Infect Dis 130:231-239.
5. James JA, Harley JB. 1992. Linear epitope mapping of an Sm B/B′ polypeptide. J Immunol 148:2074-2079.
6. Levitskaya J, Coram M, Levitsky V. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
7. McClain MT, Ramsland PA, Kaufman KM, James JA. 2002. Anti-Sm autoantibodies systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J Immunol 168: 2054-2062.
8. Peterson J, Rhodes G, Roudier J, Vaughan JH. 1990. Altered immune response to glycine-rich sequences of Epstein-Barr Nuclear Antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 33:993-1000.
9. Rhodes G, Rumpold H, Kurki P, Patrick KM, Carson DA, Vaughan JH. 1987. Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. J Exp Med 165:1026-1040.
10. Rumpold H, Rhodes GH, Bloch PL, Carson DA, Vaughan JH. 1987. The glycine-alanine repeating region is the major epitope of the Epstein-Barr Nuclear Antigen-1 (EBNA-1). J Immunol 138:593-599.
11. Vaughan JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH. 1995a. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest 95: 1316-1327.
12. Vaughan JH, Valbracht JR, Nguyen MD, Handley HH, Smith RS, Patrick K, Rhodes GH. 1995b. Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J Clin Invest 95:1306-1315.